Eli Lilly's Market Value Soars as Rival's Weight-Loss Pill Stumbles
Eli Lilly, the pharmaceutical giant, just saw its market value climb even higher, now crossing the trillion-dollar mark, after news broke about a setback for rival Kailera Therapeutics. Kailera's new oral pill for weight loss showed good results in late-stage tests in China but came with unexpectedly high rates of stomach problems, making investors rethink its competitive edge.

:max_bytes(150000):strip_icc()/TrumpVsPowell3-f3e4bdd1e02e4ddd8b0c1a5c1887b720.jpg)










-4d68af2f-5d9c-4ef8-b6c0-b37e09a3eb51.png)




